We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-7.99%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.4B
AUM Growth
-$2.28B
Cap. Flow
-$623M
Cap. Flow %
-3.38%
Top 10 Hldgs %
32.43%
Holding
345
New
22
Increased
43
Reduced
37
Closed
30

Top Buys

Rank Stock Value
1
TWTR
Twitter, Inc.
TWTR
+$314M
2
DT icon
Dynatrace
DT
+$312M
3
CSGP icon
CoStar Group
CSGP
+$301M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$249M
5
CLVT icon
Clarivate
CLVT
+$237M

Top Sells

Rank Stock Value
1
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$411M
2
RTX icon
RTX Corp
RTX
+$335M
3
CERN
Cerner Corp
CERN
+$312M
4
AVGO icon
Broadcom
AVGO
+$257M
5
PLAN
Anaplan, Inc.
PLAN
+$102M

Sector Composition

Rank Sector Weight
1 Healthcare 30.85%
2 Technology 17.59%
3 Financials 14.68%
4 Industrials 9.18%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRKR icon
51
Bruker
BRKR
$8.14B
$88.3M 0.48%
1,406,800
+345,000
+32% +$21.2M
CYTK icon
52
Cytokinetics
CYTK
$10.4B
$88.2M 0.48%
2,245,038
+362,439
+19% +$14.6M
TPTX
53
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$87.3M 0.47%
+1,160,000
New +$51.6M
SWCH
54
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$78.1M 0.42%
+2,330,000
New +$75.3M
ABBV icon
55
AbbVie
ABBV
$435B
$77.4M 0.42%
505,515
-639,152
-56% -$97.7M
INSP icon
56
Inspire Medical Systems
INSP
$1.74B
$75.4M 0.41%
413,000
+129,500
+46% +$25.8M
ENTA icon
57
Enanta Pharmaceuticals
ENTA
$400M
$73.3M 0.4%
1,550,000
– –
SIMO icon
58
Silicon Motion
SIMO
$8.68B
$65M 0.35%
+776,510
New +$65.4M
RVMD icon
59
Revolution Medicines
RVMD
$44B
$63.3M 0.34%
3,250,000
– –
PCG icon
60
PG&E
PCG
$38.5B
$62.9M 0.34%
6,305,142
– –
BPMC
61
DELISTED
Blueprint Medicines
BPMC
$61.2M 0.33%
1,211,987
-145,000
-11% -$8.49M
BIIB icon
62
Biogen
BIIB
$30.7B
$56.8M 0.31%
278,499
+80,700
+41% +$16.5M
LHCG
63
DELISTED
LHC Group LLC
LHCG
$45.2M 0.24%
+290,000
New +$47.8M
CTLT
64
DELISTED
CATALENT, INC.
CTLT
$45M 0.24%
419,755
-296,800
-41% -$30.2M
TSEM icon
65
Tower Semiconductor
TSEM
$28.5B
$43.9M 0.24%
+950,000
New +$45.2M
SAIL
66
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$41M 0.22%
+653,534
New +$40.3M
AMRS
67
DELISTED
Amyris Inc.
AMRS
$39.2M 0.21%
21,209,882
+4,278,455
+25% +$12.6M
IOVA icon
68
Iovance Biotherapeutics
IOVA
$2.87B
$35.1M 0.19%
3,176,773
-2,998,584
-49% -$39.3M
IMGO
69
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$33.1M 0.18%
2,471,313
– –
ZEN
70
DELISTED
ZENDESK INC
ZEN
$32.6M 0.18%
440,000
-190,000
-30% -$18.7M
BRMK
71
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$32.5M 0.18%
4,850,000
– –
VG
72
DELISTED
Vonage Holdings Corporation
VG
$32.5M 0.18%
1,727,000
+735,000
+74% +$14.1M
AGIO icon
73
Agios Pharmaceuticals
AGIO
$1.93B
$29.6M 0.16%
1,333,012
– –
GATE
74
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$29.3M 0.16%
2,970,000
– –
PTGX icon
75
Protagonist Therapeutics
PTGX
$9.44B
$29.3M 0.16%
3,700,608
+2,566,151
+226% +$31M
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Farallon Capital Management held 345 positions worth $18.4B, down 11% from $20.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Farallon Capital Management withdrew a net $623M in Q2 2022, closing 30 positions and reducing 37 holdings. Its most notable exit was ZYNGA INC. CL A COMMON, an estimated $411M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Twitter, Inc. worth $274M.

  • Farallon Capital Management's largest Q2 2022 buy was Twitter, Inc.: 7,325,000 shares worth $274M.
  • Farallon Capital Management added most to Clarivate in Q2 2022, an estimated $237M increase.
  • Farallon Capital Management's biggest Q2 2022 reduction was AbbVie, cutting an estimated $97.7M.
  • Farallon Capital Management fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $411M.
  • Farallon Capital Management's ten largest holdings make up 32% of its $18.4B portfolio in Q2 2022.
  • Farallon Capital Management opened 22 new positions and closed 30 in Q2 2022.
  • Farallon Capital Management's portfolio value fell 11% quarter-over-quarter to $18.4B.

Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.